Abstract
IntRoduCtIon

M
ost eye diseases which lead to loss of vision involve retinal ischemia and neovascularization. Retinal neovascularization is a common pathological change in retinal vascular disorders such as retinal vein occlusion (RVO), diabetic retinopathy (DR), and retinopathy of prematurity (ROP) [1] . Neovascularization may result in complications such as retinal edema, vitreous hemorrhage, fibrovascular proliferation, and retinal detachment, which often culminate in irreversible loss of vision [2] . Currently, there is no effective therapy to restore vision loss caused by ischemic retinopathy. Previous studies have demonstrated impaired endothelial function in the retinal vasculature in patients with retinal ischemic diseases. Repair of damaged vascular endothelium in the retina may play a key role in the control of retinal neovascularization [3] . Endothelial progenitor cells (EPCs), a population of circulating cells at low concentrations, are involved in tissue regeneration through microvascular repair and facilitate re-perfusion of ischemic areas [4] . Circulating EPCs were first identified in 1997 by Asahara et al [4] as CD34+ VEGFR2+ mononuclear cells.
These cells were shown to differentiate into an endothelial phenotype, express endothelial markers, and incorporate into neovasculature at ischemic sites. Subsequent studies by other groups also demonstrated the existence of circulating EPCs [5] [6] [7] [8] . The use of EPCs as potential therapy for retinal disease has been explored in different animal models [9] . Intravenous or intravitreal injection of human CD34+ EPCs sourced from peripheral blood or bone marrow was shown to lead to their aggregation in the damaged retinal vasculature. Moreover, an apparent normalization of the damaged retinal vasculature was observed, which indicated a potential therapeutic effect [10] . Study of the distribution and function of EPCs in the setting of retinal damage and repair requires an efficient and stable method for labeling and tracking of EPCs transplanted in the retina. Fluorescence has been widely used in the last few decades. We have used 5-(and-6)-carboxyfluorescein diacetate succinimidyl ester (CFSE) to label and track EPCs in a mouse model of laser-induced retinal injury [1] . CFSE-labeled EPCs showed normal morphology; further, no significant change in survival or apoptosis rate both in vitro as well as in the retinal vascular networks was observed for at least 28d after transplantation. Nevertheless, CFSE was found to be toxic to cells at high concentrations, and the fluorescence intensity of cells rapidly decreased within 4wk [11] . We further investigated other methods for labeling and tracking of EPCs using 1,1′-dilinoleyl-3,3,3′,3′-tetramethylindocarbocyanine perchlorate linked acetylated low-density lipoprotein (DiI-AcLDL), and green fluorescent protein (GFP). DiI-AcLDL is a lipophilic fluorescent dye commonly used for labeling of EPCs and shows an intensive expression of red florescence [12] [13] . GFP is also widely used for labeling and tracking of EPCs in animal models of retinal diseases [14] [15] [16] [17] [18] . GFP signal can be detected easily and rapidly, and the expressed fusion proteins are generally not toxic to cells. However, GFP signal cannot be amplified in a controlled manner, and thus may not be amenable to detection at low expression levels. In this study, we compared these three fluorescent markers for labeling EPCs in vitro and tracked the labeled EPCs in vivo. Our purpose is to establish a reliable and simple method for labeling and tracking of EPCs in animal models, in order to further explore therapeutic application of EPCs in retinal diseases.
MAtERIALS And MEthodS
Isolation of Endothelial Progenitor Cells from human umbilical Cord Blood EPCs were isolated using a previously described method at our laboratory [1, 13] . In brief, human umbilical cord blood was collected in blood bags (Negale, China) using citrate-dextrose as an anticoagulant. Figure 1 ). The morphology of EPCs was examined by electron microscopy, which showed a single cell with tiny microvilli on the surface, heterochromatin in oblong nucleus, and various organelles in the cytoplasm (Figure 2A ). Weibel-Palade bodies, which are the storage granules of endothelial cells, were also observed in EPCs ( Figure 2B ).
Characterization of Endothelial Progenitor Cells
Labeled by CFSE, diI-AcLdL, and Green Fluorescent Protein CFSE-labeled EPCs exhibited bright green fluorescence within the cytoplasm and the nucleus. In a previous study, we demonstrated that the fluorescence intensity of EPCs increased in a dose-dependent manner up to 40 μmol/L CFSE [1] , CFSE at >40 μmol/L showed toxic effects to EPCs. Of 5 μmol/L CFSE was finally selected for the in vitro and in vivo experiments. EPCs labelled with 10 μg/mL DiI-AcLDL exhibited red fluorescence and showed similar characteristics as those observed with CFSE-labeled EPCs. Both CFSE-and DiIAcLDL-labeled EPCs exhibited strong florescence intensity at the beginning, which dropped gradually in a time-dependent (Figure 3 ). EPCs labeled with CFSE showed higher intensity than those labeled with DiI-AcLDL initially;
however, the intensity declined at a faster rate. After 28d, EPCs labeled with CFSE and DiI-AcLDL maintained about 20.23%
and 49.99% florescence intensity, respectively. On the contrary, GFP-labeled EPCs, which exhibited green fluorescence, were only detectable after 2d; however, the intensity increased dramatically up to 7d and continued to rise in a time-dependent manner. This implies that CFSE and DiI-AcLDL are suitable for short-term labeling, while GFP should be used for longterm labeling of EPCs.
Two and seven days after labeling with CFSE, DiI-AcLDL and GFP, EPCs showed minor decline in survival and adhesive capability as compared to that in control ( Figure 4) ; however, the between-group difference was not statistically significant (P>0.05). The adhesive capability of DiI-AcLDL-labeled EPCs was comparable to that in control (Figure 4 ). This suggests that CFSE-, DiI-AcLDL-, and GFP-labeling did not affect the function of EPCs. The characteristics of 3 labeling methods are summarized in Table 1 .
Protective Effect of Endothelial Progenitor Cells transplantation Against Retinal Injury Induced by Laser Photocoagulation
Mouse model of retinal injury was induced by laser photocoagulation ( Figure 5 ) and appeared as scattered white laser spots with edematous halo on fundus photography ( Figure 5B); after 28d, the edematous halo had disappeared and pigmentation and scar formation was observed ( Figure 5C ).
In the CFSE-, DiI-AcLDL-and GFP-labeled EPCs groups, alleviation of pigmentation and scar formation with some retinal blood supply was observed ( Figure 5D -5F).
tracking of Labeled Endothelial Progenitor Cells in
Injured Mouse Retina Fluorescent cells were observed on the surface of the retina 2d after the transplantation of EPCs labeled with CFSE ( Figure 6B ) and DiI-AcLDL ( Figure 6E ). Similar results were observed on fluorescein angiography.
Evans blue exhibiting red fluorescence was employed to track the distribution of green CFSE-labeled EPCs, while green fluorescent sodium was used to track red DiI-AcLDL in the transplanted EPCs (Figure 7) . 
dISCuSSIon
A mouse model of retinal injury induced by laser photocoagulation was employed in this study. Scattered white laser spots surrounded by edematous halo were observed after laser photocoagulation, pigmentation and scar formation were perceived at 28d. Laser photocoagulation-induced animal models of retinal injury have been widely used to evaluate the efficacy of retinoprotective therapies. For example, the extract of radix pseudostellariae was found to exhibit a protective effect against retinal laser injury in rabbits [19] . We showed DiI-AcLDL (D: 7d; E: 14d; F: 28d) and GFP (G: 7d; H: 14d; I: 28d) was examined by confocal laser scanning microscopy (magnification ×400).
J: Statistical analysis of the fluorescent intensity of EPCs labeled by CFSE, DiI-AcLDL and GFP over time. Data were presented as mean±SEM. [20] , ischemic retinopathies [21] , and DR [22] [23] , by promoting vascular repair and reversing ischemic injury. Caballero et al [9] demonstrated that healthy EPCs could effectively repair ischemic vascular damage in neonatal animal models of oxygen-induced retinopathy. Medina et al [24] reported that direct incorporation of EPCs in the resident vasculature led to a significant decrease in avascular areas and an increase in normovascular areas, and prevented pathological preretinal neovascularization.
Comparing three endothelial progenitor cells trackers in laser-injured retina
However, identification and localization of engrafted EPCs are key challenges in this therapeutic strategy. In order to monitor the migration and differentiation of EPCs following transplantation, several non-invasive in vivo tracking imaging techniques, such as nuclear medicine and fluorescence imaging, have been investigated. Owing to their simplicity and relative safety, fluorescence labeling methods have been frequently used to identify and track EPCs in preclinical and biological studies. Moreover, fluorescence labeling represents a faster and more accurate modality to obtain experimental data [25] . In our previous study, we labeled EPCs by CFSE in vitro and tracked them successfully in vivo in a mouse model of retinal injury [1] . CFSE is a lipophilic molecule which displays minimal fluorescence until it enters cells by passive diffusion, where intracellular esterases cleave the acetyl groups to yield highly fluorescent, amine reactive fluorophores [26] [27] . The fluorescence intensity of CFSE in labeled EPCs was found to decrease rapidly in a time-dependent manner. The reason is that fluorescence is inherited by daughter cells after either cell division or cell fusion [28] . In this study, we further employed two other agents for fluorescence, i.e. DiI-AcLDL and GFP, and compared their relative advantages and disadvantages. Low-density [12] [13] . DiI-AcLDL-labeled EPCs displayed intensive expression of red florescence, and the florescence lasted for several weeks even though the intensity showed a gradual decline. The fluorescent intensity of DiI-AcLDL-labeled EPCs seemed lower than that of EPCs in the CFSE group; however, the decay rate of DiI-AcLDL was also lower than that of CFSE. After 28d, EPCs labeled by DiI-AcLDL maintained about 49.99% fluorescence intensity, while those in the CFSE group exhibited only 20.23% intensity. The rapid decrease in fluorescence intensity of CFSE and DiI-AcLDL over time is a disadvantage, which limits their use for long-term imaging. In such cases, another kind of fluorescence GFP was investigated. GFP can be transfected into cells, typically by plasmid or virus as vectors, or into transgenic mice [29] . We have applied liposomal and nonliposomal transfection reagents to transfect GFP into EPCs; however, we found it difficult to get stable transfected cells due to low transfection rate and short expression time of the transient transfection (data not shown). Thus, in this experiment, we employed lentivirus to mediate GFP transfection in EPCs. EPCs transfected with GFP using lentivirus showed a time-dependent increase in florescence intensity which reached up to a 30% positive labeling rate; the associated fluorescence was stable and lasted longer than that associated with use of CFSE and DiI-AcLDL. However, folding of GFP into its active, fluorescent form is quite slow and occurs over hours, which makes it unsuitable for study of fast transcriptional activation processes. The weak light emitted by GFP, poor resistance to photobleaching, and low protein expression in certain environments limit its application for labeling of EPCs. Moreover, lentivirusmediated GFP transfection in EPCs requires a complicated and time-consuming operative procedure. The potential risks of viral replication and carcinogenicity associated with the use of lentivirus is also a safety issue in pre-clinical and clinical application. Three kinds of fluorescent markers showed different outcomes, advantages and disadvantages. Cell labeling did not affect cell morphology, survival, or adhesion at 2 and 7d, which suggests that cell labeling did not influence the physiological functioning of EPCs. The positive labeling rate with use of CFSE, DiI-AcLDL, and GFP was 95%, 80% and 30%, respectively; a similar trend was observed with respect to the initial fluorescence intensity (high to low, respectively). Duration of fluorescence was lowest with CFSE and highest with GFP; the latter was associated with the highest operational difficulty and experimental cost. The characteristics of CFSE, DiI-AcLDL, and GFP were also evaluated in vivo in a mouse model of retinal injury. Fluorescent cells were observed on the surface of retina for 2d after transplantation of EPCs labeled with CFSE and DiIAcLDL. After 7d, a lot of CFSE-labeled EPCs were found to have aggregated at the sites of injury, and the intensity of green fluorescence emitted by CFSE-labeled EPCs looked stronger than the red DiI-AcLDL fluorescence at each time-point. Twenty eight days later, fluorescent cells in the CFSE and DiI-AcLDL groups were found distributed among the retinal layers, and especially in the retinal nerve fiber layer and the inner nuclear layer. Although the grafted EPCs still expressed visible fluorescence at 28d, the intensity declined thereafter. More intense cell staining may be required for a longer term study in order to overcome the fluorescence decay due to cell division. Results of angiography were similar to those of frozen section. However, fluorescent sodium caused obvious leakage due to its small molecular weight, and thus could not exhibit clear retinal vascular structure. Evans blue angiography of the retina clearly displayed retinal microvasculature. GFPlabeled EPCs were not detected in vivo although they did show a protective effect against laser damage. This could be due to: 1) loss of GFP owing to its water-solubility, or deformation during sample preparation; 2) GFP-labeled EPCs did not express GFP or the expression of GFP was too low to be detected; 3) photobleaching was observed in GFP-labeled EPCs. We are still working to improve the experimental protocol. In summary, the three kinds of fluorescent markers used in this study have their own inherent advantages and disadvantages. CFSE and DiI-AcLDL are suitable for short-term EPClabeling, while GFP should be used for long-term labeling. The choice of fluorescent agents should be based on the purpose of the study.
